Name: Latest research reports of Dr. Reddy's Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Dr. Reddy's Laboratories Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Dr. Reddy's Laboratories Ltd.

NSE: DRREDDY | BSE: 500124 | ISIN: INE089A01031 | Industry: Pharmaceuticals
| Mid-range Performer

1317.9000 -7.40 (-0.56%)

NSE Jun 23, 2025 15:31 PM

29.21% Gain from 52W Low

Volume: 843.9K

Dr. Reddy's Laboratories Ltd.

24 Jan 2025

1317.90

-0.56%

Dr Reddys Labs (HOLD): NRT business to require huge marketing spend

Hold: Dr. Reddy's Laboratories Ltd.

BOB Capital Markets Ltd.

North America sales missed our estimates and reported US$ 395mn in 3QFY25 vs US$ 445mn in 2QFY25 impacted by gRevlimid

Dr. Reddy's Laborato.. has an average target of 1343.25 from 9 brokers.